Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chiou

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
European Journal of Pharmacology|March 19, 1999
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptorJ R Wu-Wong, D B Dixon, W J Chiou, et al.
Leukemia|April 7, 2006
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndromeC-Y Chen, L-I Lin, J-L Tang, et al.
Journal of Medicinal Chemistry|August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)G Liu, K J Henry, B G Szczepankiewicz, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonistT J Opgenorth, A L Adler, S V Calzadilla, et al.
Oncology|July 1, 1997
Weekly CAF chemotherapy for advanced breast cancer patientsW S Hwang, C A Hsiung, W S Ko, et al.
Leukemia & Lymphoma|November 9, 2001
Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexaP M Chen, T J Chiou, I T Yu, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Bone Marrow Transplantation|March 2, 2010
Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation GroupA Yoshimi, R Suzuki, Y Atsuta, et al.
Journal of Medicinal Chemistry|December 1, 2001
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor modelsB G Szczepankiewicz, G Liu, H S Jae, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
European Journal of Pharmacology|March 19, 1999
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptorJ R Wu-Wong, D B Dixon, W J Chiou, et al.
Leukemia|April 7, 2006
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndromeC-Y Chen, L-I Lin, J-L Tang, et al.
Journal of Medicinal Chemistry|August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)G Liu, K J Henry, B G Szczepankiewicz, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonistT J Opgenorth, A L Adler, S V Calzadilla, et al.
Oncology|July 1, 1997
Weekly CAF chemotherapy for advanced breast cancer patientsW S Hwang, C A Hsiung, W S Ko, et al.
Leukemia & Lymphoma|November 9, 2001
Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexaP M Chen, T J Chiou, I T Yu, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Bone Marrow Transplantation|March 2, 2010
Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation GroupA Yoshimi, R Suzuki, Y Atsuta, et al.
Journal of Medicinal Chemistry|December 1, 2001
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor modelsB G Szczepankiewicz, G Liu, H S Jae, et al.
Pageof 26